Novel Transdermal Patch for Smoking Addiction Treatment

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$100,000.00
Award Year:
2009
Program:
SBIR
Phase:
Phase I
Contract:
1R43MD005181-01A1
Agency Tracking Number:
MD005181
Solicitation Year:
2009
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2009-2
Small Business Information
LOS GATOS RESEARCH
LOS GATOS RESEARCH, 67 E EVELYN AVE, STE 3, MOUNTAIN VIEW, CA, 94041
Hubzone Owned:
Y
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
928805761
Principal Investigator
 MICAH YAIRI
 (650) 965-7841
 M.YAIRI@LGRINC.COM
Business Contact
 MICAH YAIRI
Phone: (650) 965-7772
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Traditional medication-based methodologies for treating nicotine addiction have focused on delivering nicotine, most commonly via gum or a passive nicotine transdermal patch. Recently new medications, particularly bupropion and varenicline, both administered orally, have shown improved results. Despite these advances, however, long-term (one year or more) abstinence rates from smoking cigarettes still are typically less than 30%, and commonly around only 20%. Los Gatos Research is developing an alternative, transdermal delivery method to treat nicotine addiction that has the potential to significantly improve this long-term success rate. Using a novel programmable transdermal patch and a method for optimizing skin penetration rates for specific pharmaceutical formulations, for this NIH SBIR project LGR proposes to develop a platform combining both bupropion and nicotine delivery that offers extended, programmable, customizable timed medication release. In Phase I, LGR will design and test a programmable transdermal patch to independently deliver the two medications in combination. We will also optimize a novel drug delivery method to rapidly diffuse bupropion and nicotine formulations through the skin. PUBLIC HEALTH RELEVANCE: Nicotine addiction is implicated in the more than 400,000 deaths due to smoking in the United States every year. It is the greatest preventable cause of cancer, accounting for roughly one third of all cancer fatalities. Finding new and more effective methods for overcoming nicotine addiction is a critical element in the fight against drug abuse and saving lives. The work proposed for this NIH SBIR project is focused on developing a novel method for delivering bupropion and nicotine to fight nicotine addiction through the use of time-controlled, programmable transdermal drug delivery.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government